All Products

Displaying Products by Catalog Number (1800 - 1899)

Cat. No. Product Name / Activity
1800 WKYMVm
FPR1, FPR2 and FPR3 receptor agonist
1801 WAY 161503 hydrochloride
Potent and selective 5-HT2C agonist
1802 2B-(SP)
Selective GSK-3 phosphopeptide substrate
1803 ITE
Endogenous agonist for the transcription factor aryl hydrocarbon receptor
1804 SR 2640 hydrochloride
Potent, selective LTD4 /LTE4 receptor antagonist
1806 SR 33805 oxalate
CaV1.x blocker; binds allosterically to distinct site
1807 2-Methoxyestradiol
Apoptotic and antiangiogenic agent
1808 E-4031 dihydrochloride
KV11.1 (hERG) channel blocker; inhibits rapid delayed rectifier K+ current (IKr)
1809 Altanserin hydrochloride
5-HT2A receptor antagonist
1810 Raclopride
Potent and selective D2 and D3 antagonist
1811 Modafinil
Psychostimulant
1812 Threo-methylphenidate hydrochloride
Inhibitor of dopamine and noradrenalin transporters. Psychomotor stimulant
1813 Indirubin-3'-oxime
GSK-3β inhibitor; also inhibits cdks and other protein kinases
1814 N-ArachidonylGABA
Inhibits pain in vivo
1815 Palmitoylisopropylamide
Inhibitor of FAAH
1816 ICI 63197
PDE4 inhibitor
1818 Octreotide
sst2, sst3 and sst5 agonist
1819 Demethylasterriquinone B1
Selective insulin RTK activator
1820 (+)-Clopidogrel hydrogen sulfate
Selective P2Y12 antagonist
1821 YM 976
PDE4 inhibitor
1823 NMDA Receptor - Glycine Site Tocriset™
Selection of 5 NMDA receptor (glycine site) ligands (Cat. Nos. 0219, 0281, 0742, 1493 and 0237)
1824 Kainate Receptor Tocriset™
Selection of 5 kainate receptor ligands (Cat. Nos. 0222, 1107, 0903, 1045 and 1454)
1825 Mixed NMDA Receptor Tocriset™
Selection of 5 mixed NMDA receptor ligands (Cat. Nos. 0114, 0312, 0106, 0924 and 1241)
1826 Group I mGlu Receptor Tocriset™
Selection of 5 group I mGlu receptor ligands (Cat. Nos. 0805, 0188, 1237, 1212 and 0337)
1827 Group II mGlu Receptor Tocriset™
Selection of 5 group II mGlu receptor ligands (Cat. Nos. 1208, 0975, 1209, 0971 and 0337)
1828 Group III mGlu Receptor Tocriset™
Selection of 5 group III mGlu receptor ligands (Cat. Nos. 0103, 1220, 0972, 0803 and 1209)
1829 Mixed mGlu Receptor Tocriset™
Selection of 5 mixed mGlu receptor ligands (Cat. Nos. 0805, 0975, 0103, 0337 and 1209)
1831 HS 014
Selective MC4 receptor antagonist
1832 HS 024
Highly potent MC4 receptor antagonist
1836 Seglitide
sst2 and sst5 agonist
1838 IRL-2500
Potent ETB antagonist
1840 Fostriecin sodium salt
Potent PP2A and PP4 inhibitor
1842 RHC 80267
Diacylglycerol lipase inhibitor
1843 CYN 154806
Selective sst2 antagonist
1844 BIM 23056
sst ligand
1845 Ac2-26
Annexin/lipocortin 1-mimetic; inhibits leukocyte extravasation
1846 Ac2-12
Annexin/lipocortin 1-mimetic; inhibits leukocyte extravasation
1847 Eticlopride hydrochloride
D2 and D3 antagonist (D3 > D2)
1849 EMD 66684
Potent and selective non-peptide AT1 antagonist
1850 Exo1
Inhibits Golgi-ER traffic; blocks exocytosis
1851 Glucagon-like peptide 1 (1-37) (human, rat)
Endogenous pancreatic peptide
1852 (S)-(-)-Blebbistatin
Selective inhibitor of myosin II ATPase activity. Active enantiomer of (±)-blebbistatin (Cat. No. 1760)
1853 (R)-(+)-Blebbistatin
Selective inhibitor of myosin II ATPase activity. Inactive enantiomer of (±)-blebbistatin (Cat. No. 1760)
1854 Ro 60-0175 fumarate
Potent, selective 5-HT2C agonist
1856 L-165,041
Potent PPARδ agonist
1858 Impentamine dihydrobromide
Selective H3 antagonist
1860 Eltoprazine hydrochloride
5-HT1 and 5-HT2C partial agonist
1862 PRIMA-1
Restores mutant p53 activity; induces apoptosis
1867 NSC 663284
Potent, selective Cdc25 phosphatase inhibitor
1868 U0124
Inactive analog of U0126 (Cat. No. 1144)
1869 Ipsapirone
Selective 5-HT1A agonist
1870 BTS
Selective inhibitor of skeletal muscle myosin II ATPase activity
1871 α1-Adrenoceptor Tocriset™
Selection of 5 α1-adrenoceptor ligands (Cat. Nos. 1052, 0888, 1006, 0946 and 0623)
1872 α2-Adrenoceptor Tocriset™
Selection of 5 α2-adrenoceptor ligands (Cat. Nos. 1030, 0425, 0928, 1133 and 0891)
1873 β-Adrenoceptor Agonist Tocriset™
Selection of 3 β-adrenoceptor agonists (Cat. Nos. 0948, 1747 and 1660)
1875 Mixed Adrenergic Tocriset™
Selection of 5 mixed adrenoceptor ligands (Cat. Nos. 0888, 0425, 1747, 0623 and 0952)
1876 Histamine H3 Receptor Tocriset™
Selection of 5 histamine H3 receptor ligands (Cat. Nos. 0729, 0569, 0752, 0779 and 0644)
1878 MAPK Cascade Inhibitor Tocriset™
Selection of 5 MAPK cascade inhibitors (Cat. Nos. 1110, 1213, 1321, 1144 and 1202)
1881 Phosphodiesterase Inhibitor Tocriset™
Selection of 5 phosphodiesterase inhibitors (Cat. Nos. 0915, 1504, 0415, 1349 and 1046)
1882 PKA Tocriset™
Selection of 5 PKA modulators (Cat. Nos. 1337, 1140, 1099, 1288 and 1603)
1883 cGMP Dependent Kinase Inhibitor Peptide
Inhibitor of protein kinases G and A
1884 [D-Trp7,9,10]-Substance P
Inhibits M1 ACh receptor activation of Gq/11
1885 MLCK inhibitor peptide 18
Selective inhibitor of myosin light chain kinase
1889 [Leu5]-Enkephalin
Endogenous opioid agonist peptide
1891 Calcineurin Autoinhibitory Peptide
Selective calcineurin inhibitor
1893 Alytesin
Amphibian bombesin-like peptide
1894 Amyloid β-Peptide (12-28) (human)
Amyloid β-peptide; minimum required for binding to brain proteins
1898 Guanylin (human)
Endogenous activator of intestinal guanylyl cyclase
1899 Sarafotoxin S6a
Endothelin receptor agonist

Tocris Products Alphabetically by Name